6 August 2020 in Clinical Proteomics
Background: The aetiologies and pathogeneses of the joint diseases rheumatoid arthritis (RA) and spondyloarthritis (SpA) are still not fully elucidated. To increase our understanding of the molecular pathogenesis, we analysed the protein composition of synovial fluid (SF) from rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients.Methods: Fifty-six synovial fluid samples (RA, n = 32; SpA, n = 24) were digested with trypsin, and the resulting peptides were separated by liquid chromatography and analysed by tandem mass spectrometry. Additionally, the concentration of cell-free DNA (cfDNA) in the synovial fluid was measured, and plasma C-reactive protein (CRP) was determined.Results: Three hundred thirty five proteins were identified within the SF. The more abundant proteins seen in RA SF were inflammatory proteins, including proteins originating from neutrophil granulocytes, while SpA SF had less inflammatory proteins and a higher concentration of haptoglobin. The concentration of cell-free DNA in the SF increased together with proteins that may have originated from neutrophils. Plasma CRP levels in both RA and SpA, correlated to other acute phase reactants.Conclusions: The proteomic results underline that neutrophils are central in the RA pathology but not in SpA, and even though inhibitors of neutrophils (migration, proteinase inhibitors) were present in the SF it was not sufficient to interrupt the disease process.
1 January 2020 in Microbes and Infection
1 January 2016 in European Journal of Radiology
JAJeannette Demant Andersen
Jeannette Demant Andersen
1 March 2019 in Microbes and Infection
22 June 2020 in Infection and Immunity
MPMathilde Selmar Pedersen
NRNareen Sherzad Kader Rahman
Nareen Sherzad Kader Rahman
LHLiv Therese Holm-Nielsen
FFFaduma Yahya Mohamed Farah
Faduma Yahya Mohamed Farah
+1
The human respiratory tract pathogen Chlamydia pneumoniae (C. pneumoniae) causing mild to severe infections have been associated with the development of chronic inflammatory diseases. To understand the biology of C. pneumoniae infections several studies have investigated the interaction between C. pneumoniae and professional phagocytes. However, these studies have been conducted under non-opsonizing conditions making the role of opsonization in C. pneumoniae infections elusive. Thus, we analyzed complement and antibody opsonization of C. pneumoniae and evaluated how opsonization affects chlamydial infectivity and phagocytosis in human monocytes and neutrophils. We demonstrated that IgG antibodies and activation products of complement C3 and C4 are deposited on the surface of C. pneumoniae elementary bodies when incubated in human serum. Complement activation limits C. pneumoniae infectivity in vitro and have the potential to induce bacterial lysis by formation of the membrane attack complex. Co-culture of C. pneumoniae and freshly isolated human leukocytes showed that complement opsonization is superior to IgG opsonization for efficient opsonophagocytosis of C. pneumoniae in monocytes and neutrophils. Neutrophil-mediated phagocytosis of C. pneumoniae was crucially dependent on opsonization while monocytes retain minor phagocytic potential under non-opsonizing conditions. Complement opsonization significantly enhanced the intracellular neutralization of C. pneumoniae in peripheral blood mononuclear cells and neutrophils and almost abrogated the infectious potential of C. pneumoniae. In conclusion, we demonstrated that complement limits C. pneumoniae infection in vitro by interfering with C. pneumoniae entry into permissive cells, by direct complement-induced lysis and by tagging bacteria for efficient phagocytosis in both monocytes and neutrophils.
18 November 2020 in Medical Microbiology and Immunology